Safar Partners Leads Pirouette’s Investment Round with $5M+ Raised, ...

Your unfiltered news center. ®

The world you see depends upon the news you get. ®

HOME

ARTS

RSS

Today's Date: May 19, 2024

May and Stanley Smith Charitable Trust Partners with American Indian College Fund to Support Native Student Veterans • L.A. Care and Blue Shield of California Promise Health Plans Unveil New, Vibrant Community Resource Center in Panorama City with • HERImpact: Entrepreneurship for Impact Program Kicks Off in Chicago, Empowering Women Entrepreneurs • Upneeq® Wins 2024 Shape Skin Award, “Best for Lift”, in the Professional Treatment Category • Aramco and Spiritus to Advance Direct Air Capture Technology, Investment by Aramco Ventures • Rockwell Institute Celebrates Highest Real Estate Exam Pass Rates for First-Time Test Takers in the State of Washington • Energy Vault Holdings, Inc. Announces Inducement Grants Under NYSE Listing Rule 303A.08 • After Launching Massive Camp Giveaway for NYC Families Affected by "Summer Rising" Crisis, Brains & Motion Education (BAM!) • Historic Inaugural Class Graduates from OSU College of Osteopathic Medicine at the Cherokee Nation • Sacred Heart Celebrates 125th Anniversary • Red Door Community Raises more than $300,000 at Their Annual Luncheon Celebrating Women Working and Living with Cancer • WOMEN'S HEALTHCARE COMPANY WATKINS-CONTI RECEIVES FDA 510(K) CLEARANCE FOR NEW STRESS URINARY INCONTINENCE DEVICE YŌNI.FIT& • The AZEK Company Receives NYSE Notice Regarding Filing of Form 10-Q for the Fiscal Quarter Ended March 31, 2024 • Historic Bellevue House reopens • Xylem Inc. Declares Second Quarter Dividend of 36 Cents per Share • Avangrid to Be Acquired by Iberdrola • Dillard’s, Inc. Announces $0.25 Cash Dividend • Angels Helpers NYC 2024 Charity Gala Raises Funds for Harlem School of the Arts, Highbridge Voices • Federal, provincial and territorial ministers gather to support culture and heritage at annual meeting • Statement by the Prime Minister on Tamil Genocide Remembrance Day

Safar Partners Leads Pirouette’s Investment Round with $5M+ Raised, Extending Opportunity for Public to Invest Alongside R

PORTSMOUTH, N.H. , May 07 /Businesswire/ - Pirouette, with their innovative auto-injector platform, announced they have surpassed $5M raised in their community investment round on Wefunder, prompting them to extend the round due to overwhelming demand. This extension gives the millions that this solution is designed to help more time to invest and accelerate the pathway to making it available – a rare opportunity to join alongside renowned institutional investors like Safar Partners, Liquid 2 Ventures, and Gaingels.

Led by a team of rocket scientists from MIT, Harvard Medical School, Harvard Business School, Clarkson University, General Electric, and NASA, Pirouette is set to revolutionize drug administration – simplifying life-saving injections like Epinephrine for severe allergies and Naloxone for opioid overdose. With 21 patents awarded and additional filings underway, the investment round has captured the attention of industry leaders and investors, recognizing Pirouette's potential to disrupt the dinosaur injectables industry. The company's mission to simplify injectable treatments aligns with the growing demand for patient-centric healthcare solutions – 93% of surveyed patients and 70% of surveyed prescribers are eager to switch to Pirouette’s patented epinephrine auto-injector when it is approved and becomes available.

"We are overjoyed by the enthusiasm and support from our community of investors," says Conor Cullinane, PhD, CEO and Co-founder of Pirouette Medical. "With severe allergies on the rise and the opioid crisis escalating, this touches everyone, and the need for our innovative autoinjector has never been greater."

Matthew Kane, The COO of Pirouette Medical added, "This funding is a crucial step towards bringing our groundbreaking device to market, aiming to enable life-saving medications that are within easy reach of those in need."

Pirouette’s investment round is still open to the public for a limited time through Wefunder, the leading platform for early-stage retail investing, with an opportunity for anyone who is impacted or has a loved one who is impacted to invest and own a stake in the company.

For more information about Pirouette Medical and to participate in reimagining injections, visit wefunder.com/pirouette. Investments start from $100 and up to $500,000+.

About Pirouette Medical:

Pirouette Medical strives to revolutionize the healthcare industry with its innovative auto-injector technology by making life-saving injections as simple as pushing a button. Founded by experts from MIT, HMS, HBS, and Clarkson University, Pirouette aims to transform the $600 billion injectable medication market. With 21 patents awarded, backed by Y Combinator, Safar Partners, Liquid 2 Ventures, and Gaingels, Pirouette is dedicated to making critical treatments accessible and less intimidating for patients.